Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457768 · ClinicalTrials.gov registry record
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response
A clinical trial of Hepatitis C, Chronic, sponsored by Gilead Sciences.
- Completed
- Registry status
- 570
- Enrollment target
- 20
- Study locations
NCT01457768: Completed study of Hepatitis C, Chronic, sponsored by Gilead Sciences.
NCT01457768 is a study of Hepatitis C, Chronic that has completed, run by Gilead Sciences. The registered enrollment target is 570 participants, above the 354-participant average among 26 other Hepatitis C, Chronic trials with a reported enrollment target (61% higher). The trial reports 20 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01457768, a study of Hepatitis C, Chronic, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- 570 participants
- Enrollment target
- 20
- Study locations
Study Summary
This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
Conditions Studied
Study Locations (20)
California
- Advanced Clinical Research Institute, LLC - Anaheim
- Franco Felizarta, MD - Bakersfield
- Southern California Medical Group - Coronado
- West Coast Clinical Trials, LLC - Costa Mesa
- UC Davis Medical Center - Davis
- Kaiser Permanente Institute for Health Research - La Jolla
- Scripps Clinic - La Jolla
- University of California San Diego - La Jolla
- eStudySite - La Mesa
- VA Long Beach Healthcare System - Long Beach
- Kaiser Permanente of Colorado - Los Angeles
- Peter J. Ruane, MD, Inc. - Los Angeles
- 8631 West 3rd Street - Los Angeles
- California Liver Institute - Los Angeles
- Anthony Mills MD, Inc - Los Angeles
Alabama
- Birmingham Gastroenterology Associates - Birmingham
- University of Alabama at Birmingham - Birmingham
- Digestive Health Specialists - Dothan
Arizona
- Mayo Clinic - Phoenix
- University of Arizona - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 570 participants |
| Start Date | 2011-12-19 |
| Est. Completion | 2018-04-09 |
What the finished NCT01457768 record still lists
NCT01457768 is an observational study that tracks outcomes without assigning an intervention. The registered 570 participants enrollment target is mid-sized for trials with a published cap, above the 354-participant average among 26 other Hepatitis C, Chronic trials with a reported enrollment target (61% higher).
The record links to 1 condition, with Hepatitis C, Chronic appearing as the primary indexed condition, and to 0 interventions.
NCT01457768 names 20 study sites across 3 states, led by California, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT01457768 about?
NCT01457768 is a clinical study titled "A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response". This Registry is designed to obtain long term data on participants who have failed to achieve sustained virologic response (SVR) while receiving at least one Gilead oral antiviral agent (OAV) in a previous Gilead-sponsored hepatitis C virus (HCV) study.
What is the current status of trial NCT01457768?
This trial is currently completed. The enrollment target is 570 participants. The study started on 2011-12-19. Estimated completion is 2018-04-09.
What conditions does trial NCT01457768 study?
This clinical trial studies the following conditions: Hepatitis C, Chronic.
Who is sponsoring clinical trial NCT01457768?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01457768 being conducted?
This trial has 20 study locations across Alabama, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis C, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01457768's enrollment target sits among peer trials
570 3rd of 26 higher than 24 of 26 other Hepatitis C, Chronic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hepatitis C, Chronic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
RECRUITING · Phase 4
-
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
ACTIVE NOT RECRUITING · Phase 4
-
IdB 1016 Treatment for Hepatitis C Disease
COMPLETED · Phase 1
-
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
COMPLETED · Phase 2
-
A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment
COMPLETED · Phase 3
-
Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- NCT07266831 · 570 participants · Phase 2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI